ANXA1 and cancer: Although ANXA1 capability to mediate cytoskeletal dynamics interacting with proteins such as profilin, F-actin and K8/1816, 17, 18 was one of the first described characteristics of the protein, the physiopathological relevance of this property in cancer has been, with some exception, largely neglected.